EUVIMEDEUVIMED entdecken
Crossref

Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair

Naoko Ida, Miyuki Okura, Saki Tanaka, Naoko Hosono, Takahiro Yamauchi

Oncology Reports · 2024

DOI: 10.3892/or.2024.8749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Naoko Ida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, University of Fukui, Matsuoka, Eiheiji, Fukui 910‑1193, Japan. Hauptthemen laut MEDLINE: Phthalazines, Poly(ADP-ribose) Polymerase Inhibitors, Piperazines, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhthalazinesPoly(ADP-ribose) Polymerase InhibitorsPiperazinesPrecursor Cell Lymphoblastic Leukemia-LymphomaDrug SynergismDNA RepairInotuzumab OzogamicinHumansCell Line, TumorApoptosisAntineoplastic Combined Chemotherapy ProtocolsCell ProliferationIndoles

Stichwörter der Autor:innen

ALLDNA repairIOPARPolaparibtalazoparib

Substanzen

PhthalazinesolaparibtalazoparibPoly(ADP-ribose) Polymerase InhibitorsPiperazinesInotuzumab OzogamicinIndoles

Autor:innen und Institutionen

  • Department of Hematology and Oncology, University of Fukui, Matsuoka, Eiheiji, Fukui 910‑1193, Japan.
  • Department of Blood Transfusion, University of Fukui Hospital, Matsuoka, Eiheiji, Fukui 910‑1193, Japan.

Zitieren

APA

Ida, N., Okura, M., Tanaka, S., Hosono, N., & Yamauchi, T. (2024). Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair. Oncology Reports. https://doi.org/10.3892/or.2024.8749

Vancouver

Ida N, Okura M, Tanaka S, Hosono N, Yamauchi T. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair. Oncology Reports. 2024. doi:10.3892/or.2024.8749

BibTeX
@article{Ida2024,
  author = {Ida, Naoko and Okura, Miyuki and Tanaka, Saki and Hosono, Naoko and Yamauchi, Takahiro},
  title = {Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair},
  journal = {Oncology Reports},
  year = {2024},
  doi = {10.3892/or.2024.8749}
}
Kostenlos starten →